Population pharmacokinetics of ethionamide in patients with tuberculosis

Tuberculosis

Volumn 82, Issue 2-3, 2002, Pages 91-96

  Zhu, M ^a,b   Namdar, R ^a   Stambaugh, J J ^b   Starke, J R ^c   Bulpitt, A E ^a   Berning, S E ^a,d   Peloquin, C A ^a,d,e  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b A G Holley State Hospital   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHIONAMIDE;

ADOLESCENT; ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SCHOOL CHILD; TABLET; TUBERCULOSIS; UNITED STATES; VOLUNTEER;

EID: 0036397476     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1054/tube.2002.0330     Document Type: Article

References (12)

1. Berning S E, Peloquin C A. Antimycobacterial agents: Ethionamide. In: Yu V L, Merigan Jr. T C, Barriere B L, eds. Antimicrobial therapy and vaccines. Baltimore: Williams and Wilkins, 1999: pp. 650-654.
2. Jenner P J, Ellard G A, Gruer P J, Aber V R. A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man. J. Antimicrob Chemother 1984; 13: 267-277.
3. Jenner P J, Smith S E. Plasma levels of ethionamide and prothionamide in a volunteer following intravenous and oral dosages. Lepr Rev 1987; 58: 31-37.
4. Peloquin C A, James G T, McCarthy E, Goble M. Pharmacokinetic evaluation of ethionamide suppositories. Pharmacotherapy 1991; 11: 359-363.
5. Malone R S, Fish D N, Spiegel D M, Childs J M, Peloquin C A. The effect of hemodialysis on cycloserine, ethionamide, para-aminosalicylate, and clofazimine. Chest 1991; 116: 984-990.
6. Auclair B, Nix D E, Adam R D, James G T, Peloquin C A. Pharmacokinetics of ethionamide under fasting conditions, with orange juice, food, and antacids. Antimicrob Agents Chemother 2001; 45: 810-814.
7. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-1395.
8. Peloquin C A, James G T, McCarthy E. Improved HPLC assay for the determination of ethionamide in serum. J. Chromatogr 1991; 563: 472-475.
9. Jelliffe R W, Schumitzky A, Guilder M V. User manual for version 10.7 USC*PACK collection of PC programs. Laboratory of Applied Pharmacokinetics, University of Southern California, Los Angeles, 1995.
10. Cockroft D W, Gault M H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 10: 31-41.
11. Pharsight Corporation. WinNonlin Version 3.0. Examples Guide. Pharsight Corporation, California Mountain View, 1998.
12. Peloquin C A. Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin Chest Med 1997; 18: 79-87.